Related Experiment Video
Updated: Jan 30, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
[The association between vitamin D/calcium deficiency and cardiovascular events.]
Takayuki Hamano1, Sayoko Yonemoto2
1Department of Inter-Organ Communication Research in Kidney Disease, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Insights
Severe hypocalcemia can cause heart failure, a condition known as hypocalcemic cardiomyopathy. Active vitamin D treatment did not reduce cardiovascular events in hemodialysis patients with low parathyroid hormone levels.
Area of Science:
- Cardiology
- Nephrology
- Endocrinology
Background:
- Extreme hypocalcemia, often due to vitamin D and calcium deficiency, is linked to heart failure, termed hypocalcemic cardiomyopathy.
- This condition affects various age groups, including the elderly and infants.
- Hypocalcemia in chronic kidney disease (CKD) and heart failure patients predicts poorer outcomes.
Purpose of the Study:
- To evaluate the efficacy of active vitamin D analogues in reducing cardiovascular events in CKD patients.
- To investigate whether the benefits of vitamin D therapy are restricted to patients with elevated parathyroid hormone (PTH) levels.
Main Methods:
- Analysis of observational studies and a randomized controlled trial (J-DAVID study).
- Focus on hemodialysis patients with varying parathyroid hormone (PTH) levels.
Main Results:
- Observational studies suggest active vitamin D reduces cardiovascular events, but indication biases exist.
- The J-DAVID randomized trial found no reduction in cardiovascular events with alfacalcidol in hemodialysis patients with intact PTH < 180 pg/mL.
Conclusions:
- The cardiovascular benefits of active vitamin D analogues may be limited to CKD patients with high PTH levels.
- Alfacalcidol did not demonstrate efficacy in preventing cardiovascular events in hemodialysis patients with PTH < 180 pg/mL.
Abstract:
According to some case reports, extreme hypocalcemia induced by vitamin D and calcium deficiency leads to heart failure. This rare clinical entity "Hypocalcemic cardiomyopathy" is also reported in elderly patients as well as infants. In patients with chronic kidney disease and heart failure, hypocalcemia is reported to predict worse outcome. Prescription of active vitamin D or its analogues is associated with lower rates of cardiovascular events in predialysis and dialysis patients, however indication biases often seen in observational studies cannot preclude the possibility that the benefit of these agents is limited to patients with high parathyroid hormone(PTH)levels. In fact, J-DAVID study, a randomized controlled trial from Japan, clearly showed that oral administration of alfacalcidol of 0.5 μg/day did not reduce cardiovascular events in hemodialysis patients with intact PTH<180 pg/mL.
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Vitamins
Association Areas of the Cortex
Prefrontal Association Area: This area is located in the frontal lobe and is involved in planning, decision-making, and moderating social behavior. It connects with primary motor areas,...
Overview of the Cardiovascular System
Heart
The heart is the central pump of the cardiovascular system that circulates blood throughout the body. It comprises two atria receiving the blood and two ventricles pumping blood out of the heart. Their rhythmic contractions, called heartbeats, ensure that blood flow remains continuous.
Blood Vessels
Blood...
Associative Learning
Classical conditioning, also known...
Integration of Synaptic Events

